| WELLINGTON EMERGING MARKETS RESEARCH EQUITY D EUR ACC | RVI EMERGENTES | 13,428100 | 18/12/2025 | 16,89% | 32,24% | ** |
| ABACO GLOBAL VALUE OPPORTUNITIES, FI C | RVI GLOBAL VALOR | 8,679692 | 18/12/2025 | 16,88% | 37,22% | *** |
| CHALLENGE PACIFIC EQUITY SH-A | RVI ASIA | 19,022000 | 18/12/2025 | 16,88% | 40,76% | ***** |
| GOLDMAN SACHS FRONTIER MARKETS DEBT (HARD CURRENCY) X CAP EUR (HEDGED I) | RFI EMERGENTES | 345,500000 | 18/12/2025 | 16,88% | 50,94% | ***** |
| JPM ASIA PACIFIC EQUITY I2 (ACC) EUR | RVI ASIA EX-JAPÓN | 181,230000 | 18/12/2025 | 16,88% | 42,26% | ***** |
| LO FUNDS - TARGETNETZERO EMERGING MARKETS EQUITY SEED (EUR) M CAP | RVI EMERGENTES | 6,955300 | 17/12/2025 | 16,88% | 21,34% | ** |
| NINETY ONE GSF EUROPEAN EQUITY FUND A ACC EUR | RVI EUROPA | 82,060000 | 18/12/2025 | 16,88% | 50,27% | ***** |
| ROBECO CHINESE EQUITIES I USD | RVI CHINA | 167,556959 | 18/12/2025 | 16,88% | 9,76% | ** |
| BLACKROCK SYSTEMATIC ESG WORLD EQUITY I2 EUR HEDGED | RVI GLOBAL | 250,810000 | 18/12/2025 | 16,87% | 67,28% | ***** |
| BNP PARIBAS EASY ESG EUROZONE BIODIVERSITY LEADERS PAB TRACK I CAP | BIOTECNOLOGÍA | 157,145000 | 16/12/2025 | 16,87% | 50,94% | ***** |
